Bidirectionality of cardiovascular risk factors in patients with urolithiasis: current state of the problem
- Авторлар: Murkamilov I.T1, Aitbaev K.A2, Fomin V.V3, Murkamilova Z.A4, Yusupov F.A5, Schastlivenko A.I6
-
Мекемелер:
- I.K. Akhunbaev Kyrgyz State Medical Academy
- Research Institute of Molecular Biology and Medicine
- I.M. Sechenov First Moscow State Medical University
- Kyrgyz Russian Slavic University
- Osh State University
- Vitebsk State Order of Peoples Friendship Medical University
- Шығарылым: № 4 (2021)
- Беттер: 132-137
- Бөлім: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/312665
- DOI: https://doi.org/10.18565/urology.2021.4.132-137
- ID: 312665
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
Авторлар туралы
I. Murkamilov
I.K. Akhunbaev Kyrgyz State Medical AcademyPh.D., acting associate professor of Department of Faculty Internal Medicine Bishkek, Kyrgyzstan
K. Aitbaev
Research Institute of Molecular Biology and Medicine
Email: kaitbaev@yahoo.com
Ph.D., MD, professor, Head of the Laboratory of Pathophysiology Bishkek, Kyrgyzstan
V. Fomin
I.M. Sechenov First Moscow State Medical University
Email: fomin_vic@mail.ru
Ph.D., MD, professor, corresponding member of RAS, Head of the Department of Faculty Internal Medicine №1 Moscow, Russia
Zh. Murkamilova
Kyrgyz Russian Slavic University
Email: murkamilovazh.t@mail.ru
correspondence Ph.D. student at the Department of Internal Medicine No2 Bishkek, Kyrgyzstan
F. Yusupov
Osh State University
Email: furcat_y@mail.ru
Ph.D., MD, professor, Head of the Department of Neurology, Neurosurgery and Psychiatry Faculty of Medical Faculty Osh, Kyrgyzstan
A. Schastlivenko
Vitebsk State Order of Peoples Friendship Medical University
Email: andrei.schastlivenko@mail.ru
Ph.D., associate professor of Department of General Practitioner with a course of polyclinic therapy Vitebsk, Belarus
Әдебиет тізімі
- Пепенин В.Р., Спиридоненко В.В., Комаревцев В.Н., Беличенко О.В., Пепенин С.В. Роль цитратной терапии при лечении уратного уролитиаза с помощью малоинвазивных технологий. Здоровье мужчины. 2011 ;4:140-147
- Türk C., Petnk A., Sarica K., et al. EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis. Eur Urol.2016;69(3):468-474. https://doi.org/10.1016/j.eururo.2015.07.040
- William J. H. Epidemiology of kidney stones in the United States. Nutritional and Medical Management of Kidney Stones. Humana. Cham. 2019. С. 3-17. https://doi.org/10.1007/978-3-030-15534-6_1
- Evan A.P. Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr. Nephrol. 2010;25:5:831-841. https://doi.org/10.1007/s00467-009-1116-y
- Россоловский А.Н., Березинец О.Л., Блюмберг Б.И. Мочекаменная болезнь: эволюция представлений (обзор). Бюллетень медицинских интернет-конференций. Общество с ограниченной ответственностью «Наука и инновации». 2014;4(1):84- 86.
- Trinchieri A. Epidemiology of urolithiasis: an update. Clinical cases in mineral and bone metabolism.2008;5:2:101-106. PMID: 22460989.
- Romero V., Akpinar H., Assimos D.G. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12(2-3):e86-e96. PMID: 20811557.
- Turney B.W., Reynard J.M., Noble J.G., Keoghane S.R. Trends in urological stone disease. BJU Int.2012;109(7):1082-1087. https://doi.org/10.1111/j.1464-410X.2011.10495.x
- Akoudad S., Szklo M., McAdams M.A., et al. Correlates of kidney stone disease differ by race in a multi-ethnic middle aged population: The ARIC Study. Prev Med. 2010;51(5):416-420. https://doi.org/10.1016/j.ypmed.2010.08.011
- Wändell P., Carlsson A.C., Li X., et al. Urolithiasis in second-generation immigrant children younger than 18 years of age in Sweden. Acta Paediatrica.2020. https://doi.org/10.1111/apa.15298
- Alexander R.T., Hemmelgarn B.R., Wiebe N., et al. Kidney stones and cardiovascular events: a cohort study. Clinical Journal of the American Society of Nephrology. 2014;9:3:506-512. Doi: https://doi.org/10.2215/CJN.04960513
- Aviram M. Atherosclerosis: cell biology and lipoproteins - paraoxonases protect against atherosclerosis and diabetes development. Curr Opin Lipidol. 2012;23(2):169-171. https://doi.org/10.1097/MOL.0b013e3283513594
- Menon M., Resnick M.I. Urinary lithiasis: etiology, diagnosis, and medical management In: Campbell’s Urology, 8th Ed. WB Saunders Company: Philadelphia. PA. 2002. С. 3242-3305.
- Gaharwar Y.S., Topale S.S., Farouqi U., Prakash B.S. Role of atherosclerosis in pathogenesis of renal stone disease: Do all roads lead to Rome?. J Mahatma Gandhi Inst Med Sci. 2017;22:4-7. https://doi.org/10.4103/0971-9903.202014
- Skolarikos A., Straub M., Knoll T., et al. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines. Eur Urol. 2015;67(4):750-763. https://doi.org/10.1016/j.eururo.2014.10.029
- Lin S.K., Liu J.M., Chang Y.H., et al. Increased risk of endotracheal intubation and heart failure following acute myocardial infarction in patients with urolithiasis: a nationwide population-based study Ther Clin Risk Manag.2017;13:245-253. https://doi.org/10.2147/TCRM.S123702
- Ernandez T., Bonny O. Kidney stone as a cardiovascular risk marker. Rev Med Suisse 2014;10(441):1656-1660. PMID: 25322624.
- Kim S.Y., Song C.M., Bang W., et al. Nephrolithiasis predicts ischemic stroke: A longitudinal follow-up study using a national sample cohort. International journal of medical sciences.2019;16:8:1050-1056. https://doi.org/10.7150/ijms.34417
- Mackness M.I., Durrington P.N., Ayub A., Mackness B. Low serum paraoxonase: a risk factor for atherosclerotic disease? Chem Biol Interact. 1999;14:119-120:389-397. https://doi.org/10.1016/s0009-2797(99)00050-2
- Lai C.H., Huang L.C., Holby S.N., et al. Kidney stone history and adverse outcomes after percutaneous coronary intervention. Urology.2020;136:75-81. https://doi.org/10.1016/j.urology.2019.10.009
- Роюк Р.В., Яровой С.К., Гусева Н.А. и др. Эпидемиологические аспекты сочетания нефролитиаза и хронических заболеваний сердечно-сосудистой системы. Исследования и практика в медицине. 2020;7(1):38-47. https://doi.org/10.17709/2409-2231-2020-7-1-4
- Жариков А.Ю., Брюханов В.М., Зверев Я.Ф., Лампатов В.В. Современные методы моделирования оксалатного нефролитиаза. Нефрология. 2008; 12(4):28-35. https://doi.org/10.24884/1561-6274-2008-12-4-28-35
- Муркамилов И.Т., Айтбаев К.А., Фомин В.В., Юсупов Ф.А., Счастливенко А.И. Инсульт у пациентов с мочекаменной болезнью: распространенность и факторы риска. The Scientific Heritage. 2020;47(2):40-44
- Rosa D., Villa G., Montanari E., et al. The relationship between urolithiasis, metabolic syndrome and nurse shift work. A literature review.International Journal of Urological Nursing.2020. https://doi.org/10.1111/ijun.12233
- Тызьо Д.В., Ахназарян М.С., Макеева А.В. Сравнительная оценка факторов риска в патогенезе развития мочекаменной болезни почек. Научное обозрение. Педагогические науки.2019;5:115-119
- Lee Y.C., Huang S.P., Juan Y.S., Huang T.Y., Liu C.C. Impact of metabolic syndrome and its components on kidney stone in aging Taiwanese males. Aging Male. 2016;19(3):197-201. https://doi.org/10.1080/13685538.2016.1174987
- Cho S.T., Jung S.I., Myung S.C., Kim T.H. Correlation of metabolic syndrome with urinary stone composition. Int J Urol. 2013;20: 208-213. https://doi.org/10.1111/j.1442-2042.2012.03131.x
- Arafa A., Eshak E.S., Iso H. Oxalates, Urinary Stones and Risk of Cardiovascular Diseases. Medical Hypotheses. 2020.С. 109570. https://doi.org/10.1016/j.mehy.2020.109570
- Domingos F., Serra A. Metabolic syndrome: a multifaceted risk factor for kidney stones. Scand J Urol. 2014;48(5):414-419. https://doi.org/10.3109/21681805.2014.903513
- Лелявин К.Б., Селиверстова Т.Г., Рева А.А. Мочекаменная болезнь как новый компонент «метаболически здорового» ожирения. Современные проблемы науки и образования. 2019.4.URL: http:// www.science-education.ru/ru/article/view?id=29075 (дата обращения: 17.05.2020).
- Cupisti A, Meola M, DAlessandro C., et al. Insulin resistance and lowurinary citrate excretion in calcium stone formers. Biomed Pharmacother.2007;61(1):86-90. https://doi.org/10.1016/j.biopha.2006.09.012
- Taylor E.N., Mount D.B., Forman J.P., Curhan G.C. Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors. Am J Kidney Dis. 2006;47(5):780-789. https://doi.org/10.1053/j.ajkd.2006.01.024
- Wrobel B.M., Wrobel B., Hormann M., Strohmaier W.L. Overweight and obesity: risk factors in calcium oxalate stone disease? Adv Urol.2012;2012:438707. https://doi.org/10.1155/2012/438707
- Аляев Ю.Г., Кузьмичева Г.М., Руденко В.И. Современные аспекты цитратной терапии у больных мочекаменной болезнью. Врачебное сословие. 2004;4:20-24.
- Медведев В.Л., Татевосян А.С., Дмитренко Г.Д., и др. Комбинированное лечение больного с коралловидным камнем почки. Клинический случай. Инновационная медицина Кубани. 2019;(1):36-43
- Geraghty R., Abdi A., Somani B., Cook P., Roderick P. Does chronic hyperglycaemia increase the risk of kidney stone disease? results from a systematic review and meta-analysis. BMJ open. 2020;10:1. http://dx.doi.org/10.1136/bmjopen-2019-032094
- Hernandez-Baixauli J., Quesada-Vazquez S., Marine-Casado R., et al. Detection of Early Disease Risk Factors Associated with Metabolic Syndrome: A New Era with the NMR Metabolomics Assessment.Nutrients. 2020;12:3:806. https://doi.org/10.3390/nu12030806
- Ding Q., Ouyang J., Fan B., et al. Association between Dyslipidemia and Nephrolithiasis Risk in a Chinese Population. Urologia internationalis. 2019;103:2:156-165. https://doi.org/10.1159/000496208
- Гаджиев Н.К., Малхасян В.А., Мазуренко Д.А. и др. Мочекаменная болезнь и метаболический синдром. Патофизиология камнеобразования. Экспериментальная и клиническая урология.2018;1:66-75. https://doi.org/10.29188/2222-8543-2018-9-1-66-75
- Kabeya Y., Kato K., Tomita M., et al. Associations of insulin resistance and glycemic control with the risk of kidney stones. Intern Med.2012;51:699- 705. https://doi.org/10.2169/internalmedicine.51.6426
- Голованов С.А., Просянников М.Ю., Анохин Н.В., Сивков А.В., Аполихин О.И. Функциональное состояние клеточных мембран у больных мочекаменной болезнью. Экспериментальная и клиническая урология. 2019;2:87-91. https://doi.org/10.29188/2222-8543-2019-11-2-87-91
- Yanagawa K., Takeda H., Egashira T., et al. Age-related changesin alpha-tocopherol dynamics with relation to lipid hydroperoxide content and fluidity of rat erythrocyte membrane. J Gerontol A Biol Sci Med Sci. 1999;54(9):B379-B783. https://doi.org/10.1093/gerona/54.9.B379
- Kirejczyk J.K., Korzeniecka-Kozerska A., Baran M., et al. Dyslipidaemia in overweight children and adolescents is associated with an increased risk of kidney stones. Acta Paediatr.2015;104(9):e407-413. https://doi.org/10.1111/apa.13079
- Чазова И.Е., Жернакова Ю.В. от имени экспертов. Клинические рекомендации. Диагностика и лечение артериальной гипертонии. Системные гипертензии. 2019; 16(1): 6-31. https://doi.org/10.26442/2075082X.2019.1.190179
- Ljunnghall S., Hedstrand H. Renal stones and coronary heart disease. BMJ. 1976;4:5996. ID 580. https://doi.org/10.1136/bmj.4.5996.580-a
- Robertson W.G., Peacock M., Baker M. et al. Studies on the prevalence and epidemiology of urinary stone disease in man in Leeds. Br. J. Urol. 1983;55:6:595-598. https://doi.org/10.1111/j.1464-410X.1983.tb03383.x
- Shang W., Li Y., Ren Y., et al. Nephrolithiasis and risk of hypertension: a meta-analysis of observational studies. BMC nephrology.2017;18:1:344. https://doi.org/10.1186/s12882-017-0762-8
- Батько А.Б. Патологические паттерны артериальной гипертензии и мочекаменной болезни. Эффективная фармакотерапия. 2019;15:29:12-15. https://doi.org/10.33978/2307-3586-2019-15-29-12-15
- Asplin J.R., Mandel N.S., Coe F.L. Evidence of calcium phosphate super saturation in the loop of Henle. Am J Physiol.1996;270(4 Pt 2):F604-F613. https://doi.org/10.1152/ajprenal.1996.270.4.F604
- Kum F., Wong K., Game D., et al. Hypertension and renal impairment in patients with cystinuria: findings from a specialist cystinuria centre.Urolithiasis. 2019;47:4:357-363. https://doi.org/10.1007/s00240-019-01110-8
- Ferraro P.M., Bargagli M., Trinchieri A., Gambaro G. Risk of Kidney Stones: Influence of Dietary Factors, Dietary Patterns, and Vegetarian-Vegan Diets. Nutrients. 2020; 12:3:779. https://doi.org/10.3390/nu12030779
- Rendina D., De Filippo G., D’Elia L., Strazzullo P. Metabolic syndrome and nephrolithiasis: a systematic review and meta-analysis of the scientific evidence. J Nephrol. 2014;27(4):371-376. https://doi.org/10.1007/s40620-014-0085-9